• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Jin Li, Shukui Qin, +31 authors Hao Yu
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2016 (First Publication: 27 September 2016)
  • PURPOSE There is currently no standard treatment strategy for patients with advanced metastatic gastric cancer experiencing progression after two or more lines of chemotherapy. We assessed theExpand
  • Jin Li, Shukui Qin, +15 authors Hao Yu
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2013 (First Publication: 10 September 2013)
  • PURPOSE Patients with metastatic gastric cancer (mGC) who do not respond to or who experience progression with second-line chemotherapy have no treatment options that clearly confer a survivalExpand
  • Wenfeng Fang, Yunsheng Yang, +14 authors Li Zhang
  • Medicine
  • The Lancet. Oncology
  • 2018 (First Publication: 1 October 2018)
  • BACKGROUND Platinum-based doublet chemotherapy regimens, preferentially gemcitabine plus cisplatin, are generally considered the first-line standard of care for patients with recurrent or metastaticExpand
  • Fang Wu, Junhe Li, Changchen Jang, Janfeng Wang, Jianping Xiong
  • Medicine, Biology
  • International journal of clinical and…
  • 2014 (First Publication: 15 September 2014)
  • Axl, a member of receptor tyrosine kinases (RTKs), has been established as a strong candidate for targeted therapy of cancer. Some reports showed that Axl is a promising therapeutic target to enhanceExpand
  • Xinyang Liu, Shukui Qin, +15 authors Jin Li
  • Medicine
  • Journal of Hematology & Oncology
  • 2017 (First Publication: 5 September 2017)
  • BackgroundReliable biomarkers of apatinib response in gastric cancer (GC) are lacking. We investigated the association between early presence of common adverse events (AEs) and clinical outcomes inExpand